The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. Our cover story (Page 6) for this issue highlights single-treatment gene therapies and value-based contracting as a management strategy. As more gene therapies enter the marketplace with high price tags, managing this category effectively is becoming increasingly critical for payers.   

Other Spring issue highlights:   

• Myasthenia gravis  
• Ophthalmic update  
• Tumor biomarkers in breast cancer  
• Product spotlight: Leqembi  
• Pipeline
   

Explore the report